The National Asthma Council Logo

 

 

Leading the attack against asthma

Search website
Home About the NAC Strategy Managing Asthma Research Emergency
 
Asthma information Papers
 
Asthma Management Handbook Asthma Action Plans Spirometry Resources  Other Resources Information Papers Special Topics Professional Development  

Asthma Information Papers

Allergic rhinitis and the patient with asthma
Treat allergic rhinitis to manage asthma
Diagnosis
Patterns of allergic rhinitis
Management I
Management II
Management III
Management IV
Review
Levels of evidences
References
Content created Sep 2006
Content updated Sep 2006


Get Adobe Reader

Get Adobe Flash Player

 

NextBackTreat allergic rhinitis to manage asthma

Effective asthma management involves accurate recognition and appropriate treatment of allergic rhinitis. Alone, allergic rhinitis can significantly affect individuals’ daily activities and impair quality of life; when it occurs in a patient with asthma, it contributes to airway symptoms and must be considered in the management plan.

 

Contrary to the previous belief that allergic rhinitis was mainly a disorder of adults, it is now known to affect almost 8% of Australian children and adolescents.1

Rhinitis occurs in an estimated 75–80% of patients with asthma,2 with high rates reported in both atopic and non-atopic asthma.3,4 Conversely, 20–30% of patients with known allergic rhinitis also have asthma.3,5,6 Allergic rhinitis is now recognised as a risk factor for developing asthma.3,4,7–9

 

A comprehensive approach to asthma management includes investigation for allergic rhinitis and effective treatment. The presence of allergic rhinitis is associated with worse asthma control in children and adults.10,11

 

Treatment of allergic rhinitis with intranasal corticosteroids (INCS) reduces the risk of asthma-related emergency department visits and hospitalisation in patients with asthma and co-existing allergic rhinitis12 <Level II> and may improve lung function.13 <Level II> Studies assessing specific immunotherapy in children with allergic rhinitis (mainly pollen allergies) suggest that arresting the allergic response may reduce the risk of developing asthma.14,15 <Level II> (See Immunomodulatory therapy)

 Practice points
  • In patients with persistent allergic rhinitis, investigate for asthma (history, chest examination, pre-and post-bronchodilator spirometry if indicated).
     

  • In patients with asthma, investigate for rhinitis (history and physical examination).
     

  • In patients with both allergic rhinitis and asthma, treat with a combination of INCS and inhaled corticosteroids (ICS) at doses appropriate to symptom severity.

 

Allergic rhinitis in Australia1,16,17 The prevalence of allergic rhinitis is increasing. Approximately 16% of Australians have allergic rhinitis, including:
  • about 19% of working-aged adults

  • about one in four younger adults (25–44 years)

  • one in five adolescents (13–14 years)

  • one in eight primary school-aged children (6–7 years)

Approximately 10% of all Australians and 14–16% of Australian children have asthma.

Top of page